Decibel Therapeutics, Inc.
DBTXDelisted Sep 25, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001656536
Decibel Therapeutics, Inc. was delisted on Sep 25, 2023; its insiders filed their last Form 4 on Sep 25, 2023; 37 institutions reported holding it in 13F filings for Q2 2023, worth $59.2M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Decibel Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −1 vs. Q3 2022
- Shares held
- 17.5M
- −458.1K (−2.6%) vs. Q3 2022
- Total value
- $35.8M
- −$26.2M (−42.3%) vs. Q3 2022
- New holders
- 4
- 8 more added
- Sold out
- 5
- 13 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DBTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $36.4K |
| Q3 2023 | 1 | $36.4K |
| Q2 2023 | 37 | $59.2M |
| Q1 2023 | 38 | $46.7M |
| Q4 2022 | 39 | $35.8M |
| Q3 2022 | 40 | $62.1M |
| Q2 2022 | 42 | $75.2M |
| Q1 2022 | 39 | $53.8M |
| Q4 2021 | 40 | $81.7M |
| Q3 2021 | 36 | $145.9M |
| Q2 2021 | 46 | $168.1M |
| Q1 2021 | 54 | $226.3M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Decibel Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Financial Connections Group, Inc. | 300 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 222 | $0 | 0.00% | +137+161.2% | Added |
| Wells Fargo & Company | 88 | $180 | 0.00% | +2+2.3% | Added |
| Simplex Trading, LLC | 711 | $1.00K | 0.00% | −4−0.6% | Reduced |
| Bank of America Corp | 790 | $1.62K | 0.00% | −4,474−85.0% | Reduced |
| Cubist Systematic Strategies, LLC | 802 | $1.64K | 0.00% | +802 | New |
| Clear Street Markets LLC | 1,500 | $3.00K | 0.00% | +1,500 | New |
| Tower Research Capital LLC (TRC) | 9,978 | $20.0K | 0.00% | −1,720−14.7% | Reduced |
| Flagship Harbor Advisors, LLC | 10,113 | $20.7K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 10,345 | $21.2K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 10,560 | $21.6K | 0.00% | −1,512−12.5% | Reduced |
| Laurion Capital Management LP | 11,990 | $24.6K | 0.00% | 00.0% | Unchanged |
| Neuberger Berman Group LLC | 16,261 | $33.3K | 0.00% | −52,339−76.3% | Reduced |
| Northern Trust Corp | 17,043 | $34.9K | 0.00% | −1,000−5.5% | Reduced |
| Marquette Asset Management, LLC | 19,783 | $40.6K | 0.01% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 20,000 | $41.0K | 0.00% | 00.0% | Unchanged |
| Ergoteles LLC | 23,480 | $48.1K | 0.00% | +23,480 | New |
| Atlas Capital Advisors LLC | 25,000 | $51.3K | 0.01% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 27,732 | $56.9K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 34,607 | $70.0K | 0.00% | −6,734−16.3% | Reduced |
| State Street Corp | 35,160 | $72.1K | 0.00% | +18,000+104.9% | Added |
| Renaissance Technologies LLC | 36,394 | $75.0K | 0.00% | +4,094+12.7% | Added |
| Point72 Asset Management, L.P. | 90,000 | $184.5K | 0.00% | +90,000 | New |
| Bridgeway Capital Management, LLC | 111,982 | $229.6K | 0.01% | +50,000+80.7% | Added |
| Geode Capital Management, LLC | 115,567 | $236.0K | 0.00% | +4,170+3.7% | Added |
| JPMorgan Chase & Co | 130,572 | $267.0K | 0.00% | −11,687−8.2% | Reduced |
| Bronte Capital Management Pty Ltd. | 159,405 | $327.0K | 0.04% | −4,142−2.5% | Reduced |
| Barclays PLC | 238,677 | $489.3K | 0.00% | −800−0.3% | Reduced |
| Newtyn Management, LLC | 270,000 | $553.5K | 0.11% | −30,000−10.0% | Reduced |
| Harvard Management Co Inc | 328,798 | $674.0K | 0.09% | 00.0% | Unchanged |
| Millennium Management LLC | 488,783 | $1.00M | 0.00% | +171,491+54.0% | Added |
| Bessemer Group Inc | 494,071 | $1.01M | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 627,304 | $1.29M | 0.00% | +4,367+0.7% | Added |
| Samsara BioCapital, LLC | 801,629 | $1.64M | 0.35% | 00.0% | Unchanged |
| Alphabet Inc. | 1,636,258 | $3.35M | 0.19% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,787,311 | $3.66M | 0.00% | −21,675−1.2% | Reduced |
| BlackRock Inc. | 1,805,108 | $3.70M | 0.00% | −81,732−4.3% | Reduced |
| TRV GP III, LLC | 3,139,685 | $6.44M | 5.04% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 4,945,192 | $10.1M | 0.19% | 00.0% | Unchanged |
| EAM Investors, LLC | 0 | $0 | 0.00% | −236,966−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −213,107−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −157,745−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −291−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −233−100.0% | Sold out |